Anebulo Pharmaceuticals, Inc. (ANEB)

Anebulo Pharmaceuticals Statistics

Total Valuation

ANEB has a market cap or net worth of $112.98 million. The enterprise value is $101.36 million.

Market Cap	112.98M
Enterprise Value	101.36M

Important Dates

The next estimated earnings date is Wednesday, November 12, 2025, after market close.

Earnings Date	Nov 12, 2025
Ex-Dividend Date	n/a

Share Statistics

ANEB has 41.08 million shares outstanding. The number of shares has increased by 30.97% in one year.

Current Share Class	41.08M
Shares Outstanding	41.08M
Shares Change (YoY)	+30.97%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	40.54%
Owned by Institutions (%)	2.96%
Float	3.40M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	9.69
P/TBV Ratio	9.69
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 24.53

Current Ratio	24.53
Quick Ratio	23.99
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-24.14

Financial Efficiency

Return on equity (ROE) is -109.69% and return on invested capital (ROIC) is -74.52%.

Return on Equity (ROE)	-109.69%
Return on Assets (ROA)	-71.09%
Return on Invested Capital (ROIC)	-74.52%
Return on Capital Employed (ROCE)	-79.12%
Revenue Per Employee	n/a
Profits Per Employee	-$2.83M
Employee Count	3
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +44.44% in the last 52 weeks. The beta is -0.89, so ANEB's price volatility has been lower than the market average.

Beta (5Y)	-0.89
52-Week Price Change	+44.44%
50-Day Moving Average	2.47
200-Day Moving Average	1.74
Relative Strength Index (RSI)	62.91
Average Volume (20 Days)	25,690

Short Selling Information

The latest short interest is 196,744, so 0.48% of the outstanding shares have been sold short.

Short Interest	196,744
Short Previous Month	404,330
Short % of Shares Out	0.48%
Short % of Float	5.78%
Short Ratio (days to cover)	3.64

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-9.22M
Pretax Income	-8.48M
Net Income	-8.48M
EBITDA	n/a
EBIT	-9.22M
Earnings Per Share (EPS)	-$0.25

Balance Sheet

The company has $11.63 million in cash and n/a in debt, giving a net cash position of $11.63 million or $0.28 per share.

Cash & Cash Equivalents	11.63M
Total Debt	n/a
Net Cash	11.63M
Net Cash Per Share	$0.28
Equity (Book Value)	11.66M
Book Value Per Share	0.28
Working Capital	11.47M

Cash Flow

Operating Cash Flow	-6.35M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ANEB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-30.97%
Shareholder Yield	-30.97%
Earnings Yield	-7.51%
FCF Yield	n/a

Analyst Forecast

The average price target for ANEB is $8.00, which is 193.04% higher than the current price. The consensus rating is "Buy".

Price Target	$8.00
Price Target Difference	193.04%
Analyst Consensus	Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2